No Data
No Data
Nox Health Closes Acquisition of Somryst, the Only FDA-Cleared Digital Insomnia Treatment, From Pear Therapeutics
ALPHARETTA, Ga., June 20, 2023 (GLOBE NEWSWIRE) -- Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced that it has closed the acquisition of Somryst, the
BehaVR Appoints Former Pear Therapeutics, TytoCare and AVIA Executives to Senior Leadership Team
Industry veterans will support BehaVR's efforts to lower costs and improve outcomes for patients with mental and behavioral health comorbidities NASHVILLE, Tenn., June 8, 2023 /PRNewswire/ -- BehaVR
News On Pear Therapeutics Inc. (PEAR) Now Under PEARQ
News On Pear Therapeutics Inc. (PEAR) Now Under PEARQ
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersDermata Therapeutics (NASDAQ:DRMA) shares increased by 73.4% to $2.74 during Tuesday's regular session. As of 13:30 EST, Dermata Therapeutics's stock is trading at a volume of 64.5 million, whi
It's Down 82% But Pear Therapeutics, Inc. (NASDAQ:PEAR) Could Be Riskier Than It Looks
Stocks That Hit 52-Week Lows On Friday
 On Friday, 127 companies set new 52-week lows. Noteable 52-Week Lows: Infosys (NYSE:INFY) was the largest company by market cap to set a new 52-week low.Allarity Therapeutics (NASDAQ:ALLR) was the
No Data